Kazumi Fujikawa, Seed Planning Inc
Kazumi Fujikawa, Corporate Officer, Marketing & Business Development, Seed Planning Inc
Kazumi is well known in the “insight professional circle” for her distinguished experience that includes global, regional and local roles for various multinational corporation: Takeda, Pfizer, IMS, Sanofi-Aventis and has covered a range of responsibilities in her career that includes Product Commercialization Strategy, Market Research and Analytics to Logistics.
She holds BA of English Literature, Notre Dame Seishin University, Japan and holds MBA, Marketing from Leicester University, UK. She is certified, leadership and organizational development from New York University and is certified, MBTI instructor.
She is the Executive Member of Pharma Delegates after serving as a chairperson.
Masaaki Hattori, Merck
Masaaki Hattori, Commercial Excellence Head, Merck
Haruhiko Hirate, Takeda
Haruhiko Hirate, Corporate Officer, Head of Corporate Affairs and Communication, Takeda
Haruhiko Hirate became Takeda’s Corporate Communications and Public Affairs Officer in October 2014. He previously served as President of North Asia in 2011, and has held Corporate Officer and Senior Vice President positions at Takeda since 2010.
Prior to joining Takeda, Mr. Hirate held the position of Representative Senior Managing Director at GlaxoSmithKline in Japan and, before that, Representative Director and President of Banyu Pharmaceuticals, the Japanese subsidiary of Merck & Co. He joined Banyu Pharmaceuticals in 2004 from his role as Senior Vice President at Merck & Co, based in the U.S. He had previously held the position of Representative Director and President at Roche Diagnostics based in Japan and before that, Asia Pacific Regional President of Draeger.
Mr. Hirate began his career with Nissei Sangyo, a subsidiary of Hitachi, in 1980. During his career at Hitachi group companies, he lived for about five years in Germany, mainly working with former Boehringer Manheim, and a series of overseas projects in the U.S. and Asia between 1980 and 1996.
Well respected in the Japanese pharmaceutical industry, Mr. Hirate served as Director at the Federation of Pharmaceutical Manufacturers Associations of Japan (FPMAJ), and Chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) Japan. In 2012, he became a member of the Japan Association of Corporate Executives. In 2014, he became Chairman of the International Affairs Committee at the Japan Pharmaceutical Manufacturers Association (JPMA).
He graduated from Keio University in Japan with a B.A. degree in economics in 1980.
Masahiro Kajita, Eisai
Masahiro Kajita, Associate Director, Eisai
Ryota Kano, Pfizer
Ryota Kano, Center of Excellence Integrated Marketing Lead, Pfizer
Ryota Kano has been worked for Pfizer more than 15 years. Currently he is leading Center of Excellence Pfizer Essential Health Japan and focusing on resourcing optimization of the Essential Health business includes the digital transformation of a commercial model that can respond to local business needs with global/regional alignment fulfill diverse business needs with flexibility and streamlined decision making for innovate go to market model.
Sam Karita, The Boston Consulting Group
Sam Karita, Senior Partner and Managing Director, The Boston Consulting Group
Sam Karita is a Senior Partner and Managing Director in the Tokyo office of The Boston Consulting Group.
Sam is a core member of the BCG Healthcare Practice Area, Consumer Practice Area and Japan node for Marketing, Sales and Pricing Practice Area
Yuichi Kubo, Daiichi Sankyo Co. Ltd.
Yuichi Kubo, Executive Officer, Head, Global Brand Strategy, Daiichi Sankyo Co. Ltd.
Yuichi Kubo initiated his business carrier at Daiichi Pharmaceutical Co., Ltd. in 1980. He worked in areas of global regulatory affairs and clinical development in Japan (diabetes and asthma). Since 1990 he stayed in London for 6 years as a project manager for clinical development in Europe (mainly anti-bacterials).
After returning to Japan, he was responsible for implementing new Japanese GCP process and related computer systems. He was then worked for global regulatory affairs, document management, medical writing and GCP management.
At the integration of Daiichi and Sankyo, he was appointed as VP, Head of Development Research of US subsidiary at Edison, NJ, coordinating non-clinical and pharmaceutical development activities, followed by the role of Vice President for Translational Medicine and Clinical Pharmacology in Japan, and from 2012 Global Head of Intellectual Property. He was appointed to the VP, Business Development and Licensing in April 2014 and took current role in 2018.
He was trained as a biochemist and holds master degree in pharmaceutical science.
Susumu Misumori, Shionogi
Susumu Misumori, Vice President, Sales Planning Department, Shionogi
Satoru Noguchi, Celgene
Satoru Noguchi, President, Celgene
Rafaat Rahmani, Lifescience Dynamics
Rafaat Rahmani, President, Lifescience Dynamics
Rafaat founded Lifescience Dynamics in the summer of 2004. He had a vision of what would make an effective global decision support service, dedicated exclusively to pharmaceutical and biotechnology industries. It would have to be the best in class market research, competitive intelligence and market access, combined with first-rate people and a business model that met their clients’ global insight and foresight requirements. He wanted to deliver a unique service model that hadn’t been available to the market previously, giving pharmaceutical companies a new and interesting way to manage their market, competitors and payer requirements.
Lifescience Dynamics is headquartered in London with offices in New York. They are privileged to boast an extraordinary worldwide customer base, with teams across the globe supporting firms of all sizes, from top 20 pharmaceutical companies through to smaller niche pharma and biotech firms. Lifescience Dynamics has undertaken research across 86 countries.
Prior to founding Lifescience Dynamics, Rafaat was Vice President of a London-based consulting practice where he was responsible for numerous international projects for top 10 pharmaceutical companies, focusing on all aspects of the clinical development and commercialisation environments at US, European and global levels.
Rafaat holds a Bachelor Business Administration from University of Huston, Texas, USA and an MBA from the Manchester Business School, Manchester, UK.
Igor Rudychev, AstraZeneca
Igor Rudychev, Sr. Business Insights Director, AstraZeneca
Igor Rudychev, PhD, MBA (Chicago Booth) has 25 years of business experience and for the last 18 years had been specializing in pharmaceutical sales & marketing and CI/MT. Currently, Igor is Sr. Director of Business Insights with AstraZeneca, specializing in Immuno-Oncology Business Insights, CI, and MR. Previously, Igor was leading Global Samples Sales & Marketing Operations with Pfizer and was leading Global Resource Allocation & Commercial Assessment with Pfizer. Before Pfizer Igor was a Vice President of Pharmaceutical Management Consulting firm in Chicago supporting 18 out of top 20 pharmaceutical clients.
Igor has MBA in marketing & finance from University of Chicago, Booth School of Business and PhD in superstring theory & black holes from Texas A&M University.
Ajai Sulekh, Biogen
Ajai Sulekh, Managing Director and Representative Director, Biogen
Ajai Sulekh serves as Managing Director and Representative Director at Biogen Japan. He is responsible for overseeing the entire operations of the Japanese affiliate, including two business units, Multiple Sclerosis & Spinal Muscular Atrophy, and the management of functions essential to commercial operations including marketing, salesforce productivity such as data analytics, sales training, and sales incentive administration. In addition, he leads Biogen Japan’s new product planning, wholesaler management and partnership management function.
Prior to joining Biogen, he held roles of increasing responsibility in sales, product & brand management, marketing and then strategic planning and business development for a variety of pharmaceutical companies, including Eli Lilly, Abbott, MSD and most recently, Merck & Co. He draws broad perspectives in commercial area by not only spending time at the affiliates but also working at Global Head Office. Ajai also has strategy consulting experience with Accenture. He holds a Master of Science degree from Tokyo University in Japan and MBA from IMD Lausanne in Switzerland.
Hiroaki Suzuki, Vetter Pharma
Hiroaki Suzuki, Country Manager, Vetter Pharma
Hiroaki has been with Vetter Pharma International Japan, a global leading German CDMO, for 3-plus years as Country Manager. Prior to that, Hiroaki has gained extensive knowledge on Market Research / Commercial Excellence through his work at ZS Associates and Actelion Pharmaceuticals Japan, now a J&J company.
Hiroaki holds bachelor’s degree in Chemical Engineering from Waseda University and holds MBA from McDonough School of Business at Georgetown University. Hiroaki has once been as guest scientist at National Council Canada for one-year earlier in his professional career.
Azusa Tanaka, Lifescience Dynamics
Azusa Tanaka, Ph.D., Senior Consultant, Lifescience Dynamics
Azusa is bi-lingual, bi-cultural (Japanese/English) with a PhD in Immunology from the University of Chicago. Azusa is a Sr. Consultant at Lifescience Dynamics with over 10 years of experience in the pharma/biomedical research sector. She is a former global product manager of pre-clinical immuno-oncology (IO) product portfolio at Taconic Biosciences. With extensive experience in competitive intelligence projects for the Pharma Industry, Azusa has attended over 30 conferences in the US, EU, and Japan for a wide range of topics including immuno-oncology, cardiometabolic, and digital health. Her disease area focus is in immunology, oncology, and cell & gene therapy.
Atsuhito Tomotsugu, Takeda
Atsuhito Tomotsugu, Director, Takeda
Hanson Zheng, Bristol Myers Squibb
Hanson Zheng, Director, Customer Insights & Analytics, Bristol Myers Squibb